Aurinia Pharmaceuticals Inc (AUPH)

[Zeppo]

Low-priced stocks are low priced for a variety of reasons. That group, as a whole, is driven by news. When the news dries up, so do many of the stock prices. AUPH really has had a meteoric run off a Phase II test. Given the time it normally takes to get a fully enrolled Phase III test off the ground and running, one would expect a lot of quiet periods when it comes to news. So seeing AUPH's stock price beginning to trend downward some isn't unusual to me. What the market did tell me was that there was a bit of "irrational exuberance" at $10 and a bit more real value in the 6$ to 7$ range......where new accumulations are taking place.